Monthly return of equity issuer on movements in securities for the month ended 30 September 2026
Filed with HKEX · Stock code 512 · · 10 pages · English
Summary by 6ix AI
This filing is a monthly return detailing movements in securities for Grand Pharmaceutical Group Limited for a specific month. It confirms the total authorised share capital and the number of issued shares at the end of the month. The document also includes a public float sufficiency confirmation, ensuring compliance with listing rules. Additionally, it provides confirmations regarding the issuance and transfer of securities during the month.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Grand Pharmaceutical Group Limited on 6ix
Earlier from Grand Pharmaceutical
- Interim report 2026
- Notification Letter and Reply Form to Non-registered Shareholders - Notice of publication of Interim Report
- Notification Letter and Reply Form to Registered Shareholders - Notice of publication of Interim Report
- The world's first: Grand Pharma's global innovative product STC3141 successfully reached the clinical endpoint in the Phase II clinical study in China
- Voluntary announcement: the global innovation product of The Group STC3141 was approved to commence phase IIa clinical research in related to COVID-19 in Belgium
Later from Grand Pharmaceutical
All Grand Pharmaceutical news releasesFollow Grand Pharmaceutical into a list and get an email when it puts out news.
Follow Grand Pharmaceutical